SENSEI BIOTHERAPEUTICS INC (SNSE) Stock Analyst Ratings
NASDAQ:SNSE • US81728A2078
30.22 USD
-4.01 (-11.71%)
At close: Feb 26, 2026
30.6 USD
+0.38 (+1.26%)
After Hours: 2/26/2026, 8:00:02 PM
ChartMill assigns a Buy % Consensus number of 43% to SNSE. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 33.15. This target is 9.7% above the current price.
- SNSE was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about SNSE.
- In the last month the buy percentage fell by 40 points. So the trust of analysts is decreasing.
- SNSE was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-30 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-08-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-03-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-03 | Citigroup | Reiterate | Buy -> Buy |
| 2024-05-24 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | Stephens & Co. | Initiate | Overweight |
| 2023-12-04 | HC Wainwright & Co. | Initiate | Buy |
| 2022-12-13 | Citigroup | Initiate | Buy |
| 2022-10-03 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2022-03-10 | Piper Sandler | Maintains | Overweight |
| 2021-07-01 | Berenberg | Downgrade | Buy -> Hold |
| 2021-06-29 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2021-03-01 | Oppenheimer | Initiate | Outperform |
| 2021-03-01 | Piper Sandler | Initiate | Overweight |
SENSEI BIOTHERAPEUTICS INC / SNSE FAQ
What do analysts expect the price target to be for SENSEI BIOTHERAPEUTICS INC (SNSE)?
6 analysts have analysed SNSE and the average price target is 33.15 USD. This implies a price increase of 9.7% is expected in the next year compared to the current price of 30.22.
What is the consensus rating for SENSEI BIOTHERAPEUTICS INC (SNSE) stock?
The consensus rating for SENSEI BIOTHERAPEUTICS INC (SNSE) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.